Latest Feature

Big data and personalized medicine: Q&A with Definiens CEO Thomas Heydler

Definiens CEO Thomas Heydler discusses his ambition to position his company at the forefront of the coming revolution in personalized and predictive medicines.

The making of an icon | Dr. Tom Fogarty's obsession with innovation

Medtech icon Dr. Tom Fogarty tells MassDevice.com about his unconventional path from upstart tinkerer in the suburbs of Cincinnati to healthcare celebrity in the heart of Silicon Valley, in Part 1 of a 3-part series.

DNA analysis in your pocket - Q&A with QuantuMDx founder Jonathan O'Halloran

QuantuMDx envisions a future where laboratory-quality diagnostics are mobile, cheap and available to everyone, from healthcare providers in developing countries to parents dealing with ill children.

Medical device tax: At least $510B paid in 2013

A MassDevice.com analysis of reported payments for the medical device tax last year finds that 14 companies accounted for more than 97% of the nearly $500 million collected.

Breathing easier with SinuSys | MassDevice Q&A

SinuSys CEO Thomas Schreck and CMO Dr. Jerome Hester tell MassDevice.com how they hope to replace sinus surgery with a simple, in-office procedure and how a doctor and his patient formed a company together.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Medtronic touts Endurant stent graft data

April 18, 2014 by Brad Perriello

Medtronic touts positive data from a pair of clinical trials for its Endurant stent graft for treating abdominal aortic aneurysms.

Medtronic touts Endurant stent graft data

Medtronic (NYSE:MDT) said data from a pair of clinical trials evaluating its Endurant stent graft for abdominal aortic aneurysms "affirm the Endurant stent graft's durable, consistent and proven outcomes."

Cayenne Medical sues MedShape over soft tissue anchor

April 18, 2014 by Brad Perriello

Cayenne Medical levels a patent infringement lawsuit against MedShape over soft tissue anchor technology.

Cayenne Medical sues MedShape over soft tissue anchor

Cayenne Medical filed a lawsuit against rival MedShape Inc., alleging infringement of 2 of its patents covering its AperFix soft tissue anchor by MedShape's ExoShape device.

The lawsuit, filed in the U.S. District Court for Arizona, alleges that MedShape hired former Cayenne salespeople with knowledge of the 2 patents at issue, which cover Cayenne's AperFix device.

Virginia doc gets jail time in Orthofix probe

April 18, 2014 by Brad Perriello

A Virginia podiatrist is sentenced to jail time for lying to a grand jury about her involvement in a scheme to defraud Medicare by collecting reimbursement for procedures using Orthofix's bone growth stimulator.

Virginia doc gets jail time in Orthofix probe

Virginia podiatrist Dr. Ilene Terrell drew a jail sentence yesterday for lying to federal investigators probing Orthofix International (NSDQ:OFIX) and its bone-growth stimulators.

Covidien lands FDA OK for camera-equipped feeding tube

April 18, 2014 by Arezu Sarvestani

Covidien touts FDA clearance for its novel camera-equipped Kangaroo feeding tube designed to provide visualization for an otherwise blind procedure.

Covidien lands FDA OK for camera-equipped feeding tube

Medtech titan Covidien (NYSE:COV) received FDA clearance for its visual Kangaroo feeding tube, equipped with an endoscopic camera that allows physicians to see into the procedure in a new way.

ForSight Vision5 lands $15M Series C round

April 18, 2014 by Brad Perriello

ForSight Vision5 says it landed a $15 million Series C round for its Helios ocular insert.

ForSight Vision5 lands $15M Series C round

ForSight Vision5, which is developing devices to treat front-of-the-eye conditions such as glaucoma and dry eye disease, said it pulled down a $15 million Series C round.

ForSight Vision5 is a spinout of ForSight Labs, a Menlo Park, Calif.-based incubator focused on developing ophthalmic treatments.

Check out the 'bioficial' heart

April 18, 2014 by MassDevice

See video

Researchers at the University of Louisville attempt to copy a sick patient's heart with the patient's own fat cells, using a 3D printer to create a "bioficial" heart.

Another recall for Spacelabs Healthcare's Arkon anesthesia system

April 18, 2014 by Brad Perriello

The FDA slaps Spacelabs Healthcare with a Class I recall of its Arkon anesthesia system due to a software bug.

Another recall for Spacelabs Healthcare's Arkon anesthesia system

The FDA slapped Spacelabs Healthcare with a Class I recall after the medical device company pulled 16 of is Arkon anesthesia delivery devices due to a software bug.

The recall, of the Arkon device equipped with version 2.0 software, involves devices sold to hospitals in North Carolina and South Carolina, according to the FDA. The Class I recall status denotes a problem that could cause serious injury or death.

FDA warns that breaking up uterine tissue for removal may spread cancer

April 18, 2014 by Arezu Sarvestani

FDA officials warn against the use of "laparoscopic power morcellation" for the removal of uterine tissue or fibroids, saying that the procedure may cause cancer to spread beyond the uterus.

FDA warns that breaking up uterine tissue for removal may spread cancer

FDA officials issued a formal warning today asking doctors to avoid a certain method for removing uterine tissue out of concern that it may cause stealthy cancers to spread beyond the uterus.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp